Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université du Québec à Montréal

$34,200.00

Advanced bioanalytical mass spectrometry techniques for investigating the mechanism of protein binding by reactive metabolites

FY 2009-10

Summary
The main role of drug metabolism is to detoxify the body from xenobiotics, rendering them more polar and thus more easily cleared. Some drugs, however, are bioactivated into reactive metabolites having the potential to covalently bind to proteins. This binding is considered to be an important cause of idiosyncratic (rare and unpredictable) drug reactions (IDRs) and, as a result, the formation of these metabolites represents a significant liability for new pharmaceutical compounds. The way in which certain drugs exhibit their toxicity can be highly variable and the exact mechanisms are still quite unclear. Designing new methods to study these interactions would clearly benefit the field. The proposed research involves studying the covalent binding of drugs known to form reactive metabolites. By employing a combination of high-resolution liquid chromatography and advanced mass spectrometry tools, an approach will be devised for characterizing which proteins are targeted by different reactive metabolites and where these modifications occur. Thus, more insight will be gained on the mechanisms of toxicity of these drugs. New analytical strategies will be devised for studying the mechanisms of protein modification by reactive drug metabolites. Using a suite of drugs known to be involved in protein binding via chemically reactive metabolites, a systematic approach will be taken to identify important protein targets as well as elucidate the mechanism of binding. This research should have very important consequences for better understanding drug metabolism and bioactivation as well as IDRs. It could also potentially identify candidate biomarkers for this type of drug toxicity. Ultimately, if we could estimate a "danger of toxicity" level in terms of protein adducts for certain drugs known to be susceptible to this binding, a clinical test could be envisioned in order to monitor appropriate drug dosing for an individual patient.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
355933-2008
Name nom
Sleno, Lekha
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
34200
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
26
Committee name en
Anal. & Phys. Chemistry
Committee name fr
Chimie analytique et physique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
2
Nb partie
3
Application title
Advanced bioanalytical mass spectrometry techniques for investigating the mechanism of protein binding by reactive metabolites
Keyword
NA
Application summary
The main role of drug metabolism is to detoxify the body from xenobiotics, rendering them more polar and thus more easily cleared. Some drugs, however, are bioactivated into reactive metabolites having the potential to covalently bind to proteins. This binding is considered to be an important cause of idiosyncratic (rare and unpredictable) drug reactions (IDRs) and, as a result, the formation of these metabolites represents a significant liability for new pharmaceutical compounds. The way in which certain drugs exhibit their toxicity can be highly variable and the exact mechanisms are still quite unclear. Designing new methods to study these interactions would clearly benefit the field. The proposed research involves studying the covalent binding of drugs known to form reactive metabolites. By employing a combination of high-resolution liquid chromatography and advanced mass spectrometry tools, an approach will be devised for characterizing which proteins are targeted by different reactive metabolites and where these modifications occur. Thus, more insight will be gained on the mechanisms of toxicity of these drugs. New analytical strategies will be devised for studying the mechanisms of protein modification by reactive drug metabolites. Using a suite of drugs known to be involved in protein binding via chemically reactive metabolites, a systematic approach will be taken to identify important protein targets as well as elucidate the mechanism of binding. This research should have very important consequences for better understanding drug metabolism and bioactivation as well as IDRs. It could also potentially identify candidate biomarkers for this type of drug toxicity. Ultimately, if we could estimate a "danger of toxicity" level in terms of protein adducts for certain drugs known to be susceptible to this binding, a clinical test could be envisioned in order to monitor appropriate drug dosing for an individual patient.
Université du Québec à Montréal - $34,200 Grant (2009… | Canada Spends